Prospective, randomized trial comparing blood and oxygenated crystalloid cardioplegia in reoperative coronary artery

J S Shanewise1, A S Kosinski, J A Coto

  • 1Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA, USA.

Insights

Oxygenated blood and crystalloid cardioplegia are equally effective for preserving heart muscle during reoperative coronary artery bypass grafting. Transesophageal echocardiography showed no significant differences in left ventricular wall motion between the two methods.

Area of Science:

  • Cardiovascular Surgery
  • Cardiology
  • Biomedical Engineering

Background:

  • Reoperative coronary artery bypass grafting (CABG) poses significant challenges for myocardial preservation.
  • Effective myocardial protection strategies are crucial in complex cardiac surgeries.

Purpose of the Study:

  • To compare the efficacy of oxygenated blood cardioplegia versus oxygenated crystalloid cardioplegia.
  • To assess myocardial preservation during reoperative CABG using transesophageal echocardiography (TEE).

Main Methods:

  • Prospective randomized trial involving 61 patients undergoing reoperative CABG.
  • Comparison of oxygenated blood cardioplegia and oxygenated crystalloid cardioplegia via combined antegrade-retrograde delivery.
  • TEE assessment of left ventricular regional wall motion before and after cardiopulmonary bypass.

Main Results:

  • No significant differences in the change of regional wall motion scores were observed between the blood and crystalloid cardioplegia groups.
  • Both cardioplegia solutions demonstrated comparable outcomes in preserving myocardial function.

Conclusions:

  • Oxygenated blood and crystalloid cardioplegia are equally effective for myocardial preservation in reoperative CABG.
  • The choice between blood and crystalloid cardioplegia may not significantly impact immediate postoperative left ventricular function in this context.
Abstract

Related Concept Videos